When the hot flashes started, the instinct to reach for something plant-based and 'gentle' made complete sense — it feels like taking control without medicalising a natural transition. But finding out that some of those gentle options had real contraindications, especially for anyone with a history of hormone-sensitive cancer or who takes a blood thinner, was genuinely sobering. The information isn't hidden, exactly — it's just buried under a lot of very reassuring green packaging.
Learn more about Rose →Black cohosh (Actaea racemosa) is one of the most widely used herbal remedies for hot flashes, but regulatory agencies in the US, UK, Australia, and across the EU have all issued warnings linking it to rare cases of hepatotoxicity — including liver failure requiring transplantation. The mechanism is not fully understood, but immune-mediated toxic reactions are suspected, meaning susceptibility cannot be predicted in advance. Anyone with existing liver conditions, or who takes medications metabolised by the liver, carries elevated risk that product labels routinely fail to communicate.
Red clover contains isoflavones — phytoestrogens that bind to oestrogen receptors — which is precisely why it's marketed for menopausal symptoms, and precisely why it raises concern for women on tamoxifen or other selective oestrogen receptor modulators. Tamoxifen works by blocking oestrogen receptor activity in breast tissue; compounds that also bind those receptors may theoretically compete with or blunt that effect. Current evidence does not confirm catastrophic interaction in every case, but oncologists widely advise avoidance, and the risk-benefit calculation for breast cancer survivors is unfavourable.
Dong quai (Angelica sinensis) is a staple of traditional Chinese medicine and appears frequently in Western menopause supplement blends, often without adequate labelling about its coumarin content. Coumarins have anticoagulant properties, meaning dong quai can potentiate the effects of warfarin, aspirin, and other antiplatelet drugs — raising the risk of bleeding. Clinical trials have also found no significant benefit over placebo for hot flash frequency or severity, which makes the risk-benefit profile particularly unfavourable.
Wild yam (Dioscorea villosa) contains diosgenin, a compound that can be converted into progesterone in a laboratory — but the human body cannot perform that conversion. Creams marketed as 'natural progesterone' that list wild yam as their active ingredient are therefore providing no progesterone at all, and the estrogenic or progestogenic benefits claimed on their packaging are not supported by clinical evidence. Women using wild yam cream as a substitute for medically prescribed progesterone — particularly those with a uterus taking oestrogen therapy — are left with inadequately protected endometrium.
Kava (Piper methysticum) is sometimes recommended for menopause-related anxiety and sleep disturbance, and small trials have shown modest anxiolytic effects. However, it carries one of the strongest hepatotoxicity signals in the herbal supplement literature — enough for Germany, Canada, and the UK to have previously restricted or banned its sale, with some restrictions later modified but not eliminated. Liver damage cases have occurred even with short-term use at recommended doses, and the unpredictability of who is affected makes it a high-risk choice.
St. John's Wort (Hypericum perforatum) is widely used for low mood during perimenopause, and there is reasonable evidence it outperforms placebo for mild-to-moderate depression. The serious problem is that it is a potent inducer of cytochrome P450 enzymes and P-glycoprotein, meaning it accelerates the metabolism of a long list of drugs — including combined oral contraceptives (still relevant in perimenopause), tamoxifen, cyclosporine, antiretrovirals, and warfarin. Women are often not warned that taking it alongside these medications can reduce their effectiveness to clinically significant degrees.
Dietary soy consumed as whole food appears safe and may modestly reduce hot flash frequency, with reassuring long-term population data from Japan. Concentrated soy isoflavone supplements are a different matter: they deliver doses far exceeding anything achievable through food, and their interaction with oestrogen receptors in breast tissue at pharmacological doses remains an active area of research concern — particularly for women with hormone receptor-positive breast cancer or those with BRCA mutations. The distinction between food and supplement is one that marketing materials consistently fail to make.
Valerian is a popular choice for the sleep disruption that accompanies perimenopause, and it has a long folk-medicine history. Clinical trial results are inconsistent — some show modest improvement in sleep latency, others show no benefit over placebo — and the evidence base for menopause-specific sleep disruption is particularly thin. More practically, valerian potentiates the sedative effects of benzodiazepines, alcohol, and other CNS depressants, and abrupt discontinuation after prolonged use has been associated with withdrawal-like symptoms including cardiac complications in case reports.
Evening primrose oil is rich in gamma-linolenic acid and is frequently marketed for hot flashes, breast tenderness, and skin changes in menopause. A Cochrane-informed review found it performed no better than placebo for vasomotor symptoms, which is the primary reason most women take it. It also inhibits platelet aggregation, meaning combined use with anticoagulants or antiplatelet drugs raises bleeding risk — a contraindication that appears on very few retail labels.
Chasteberry (Vitex agnus-castus) acts on dopamine receptors and has demonstrated effects on prolactin levels, which is why it has plausible mechanisms for some menstrual cycle-related symptoms in early perimenopause. Because it has genuine hormonal activity, it is not an inert supplement — it can interact with dopamine-modifying medications including antipsychotics and, in theory, with hormone therapy, though robust interaction data are limited. Women with hormone-sensitive conditions or those on dopaminergic drugs should not assume it is consequence-free because it is sold without a prescription.
Melatonin is so normalised that many women consider it roughly equivalent to a chamomile tea, but it is an exogenous hormone that binds to melatonin receptors and has downstream effects on the hypothalamic-pituitary-gonadal axis — a system already in flux during perimenopause. Over-the-counter doses in the US often range from 5–10 mg, which is substantially higher than the physiologically effective dose (0.1–0.5 mg), and chronic high-dose use has not been studied in the context of menopause hormonal transition. It also interacts with blood thinners, immunosuppressants, and diabetes medications, and its legal status varies significantly by country — it is a prescription medicine in the UK, not a supplement.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.